Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVOTF) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for Evotec SE (EVOTF) over the last 8 years, with Q3 2025 value amounting to -$23625.4.

  • Evotec SE's Capital Expenditures rose 1965.76% to -$23625.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $125.6 million, marking a year-over-year decrease of 4530.22%. This contributed to the annual value of $125.5 million for FY2024, which is 4530.96% down from last year.
  • Evotec SE's Capital Expenditures amounted to -$23625.4 in Q3 2025, which was up 1965.76% from -$22004.2 recorded in Q2 2025.
  • Evotec SE's Capital Expenditures' 5-year high stood at $229.7 million during Q4 2023, with a 5-year trough of -$160225.4 in Q2 2023.
  • Its 5-year average for Capital Expenditures is $35.6 million, with a median of -$19142.2 in 2025.
  • Examining YoY changes over the last 5 years, Evotec SE's Capital Expenditures showed a top increase of 63880.28% in 2022 and a maximum decrease of 10992473.54% in 2022.
  • Evotec SE's Capital Expenditures (Quarter) stood at $136.0 million in 2021, then surged by 35.98% to $184.9 million in 2022, then increased by 24.24% to $229.7 million in 2023, then crashed by 45.3% to $125.6 million in 2024, then crashed by 100.02% to -$23625.4 in 2025.
  • Its Capital Expenditures stands at -$23625.4 for Q3 2025, versus -$22004.2 for Q2 2025 and -$19142.2 for Q1 2025.